Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ovarian Neoplasms

Free Subscription 10.11.2025 1 Am J Obstet Gynecol 1 Anticancer Drugs 2 Br J Cancer 7 Gynecol Oncol 2 Int J Cancer 1 Int J Gynaecol Obstet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. WILKE RN, Pennington KP, Gootzen TA, Steenbeek MP, et al
   Salpingectomy in individuals at high risk for tubo-ovarian cancer - consensus and precaution.
   Am J Obstet Gynecol. 2025 Nov 1:S0002-9378(25)00820.
   PubMed         Abstract available
   
   

   
   Anticancer Drugs

2. SUN S, Qian L
   Activation of the caspase-1/gasdermin D pathway via alpha-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth.
   Anticancer Drugs. 2025 Nov 5. doi: 10.1097/CAD.0000000000001789.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. LOKMAN NA, Macpherson AM, Thompson AR, Price ZK, et al
   Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer.
   Br J Cancer. 2025 Nov 5. doi: 10.1038/s41416-025-03244.
   PubMed         Abstract available
   
   
4. COLIN-LEITZINGER C, Aranzabal O, Johnson CE, Alberg AJ, et al
   Use of non-prescription analgesic medications and survival among Black women with ovarian cancer.
   Br J Cancer. 2025 Nov 5. doi: 10.1038/s41416-025-03254.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

5. BLANK SV, Frey MK
   Does a diagnosis of breast cancer reduce ovarian cancer risk in BRCA1/2 3 carriers: Why is this a question?
   Gynecol Oncol. 2025;201:A3-A4.
   PubMed        
   
   
6. NEPHEW KP, Drapkin R, Lang J, Zhuravlev Y, et al
   The 15th Biennial Rivkin Center ovarian cancer research symposium.
   Gynecol Oncol. 2025;201:A1-A2.
   PubMed         Abstract available
   
   
7. TISCHER KM, Islam NS, McGree ME, Tapia AL, et al
   Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy.
   Gynecol Oncol. 2025;203:165-170.
   PubMed         Abstract available
   
   
8. PARK J, Lee D, Kim S, Kim YN, et al
   Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression.
   Gynecol Oncol. 2025;203:151-157.
   PubMed         Abstract available
   
   
9. MOUFARRIJ S, Friedman CF, Freeman S, Green H, et al
   A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
   Gynecol Oncol. 2025;203:97-104.
   PubMed         Abstract available
   
   
10. ACKROYD SA, Sudilovsky G, Che Y, Wesevich A, et al
    Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center.
    Gynecol Oncol. 2025;201:203-209.
    PubMed         Abstract available
    
    
11. BRODSKY AL, Welte T, Vuttaradhi VK, Yang X, et al
    Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor models.
    Gynecol Oncol. 2025;201:152-159.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. HABIBURRAHMAN M, Masrour N, Patel N, Piskorz AM, et al
    Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients.
    Int J Cancer. 2025 Nov 1. doi: 10.1002/ijc.70217.
    PubMed         Abstract available
    
    
13. SABBAGHIAN A, Lin H, Lim YP
    WBP2 and its network of transcription coregulators in an expanding repertoire of human cancers.
    Int J Cancer. 2026;158:218-231.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

14. FUJITA H, Okamoto K, Kato H, Watari H, et al
    Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
    Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.